Neoemocicatrol nasal ointment 20g

NEOEMOCICATROL * UNG NAS 20G

Therapeutic indications

Disinfection of the nasal mucosa.

Dosage and method of use

Dosage Apply 2-5 cm of ointment to the nostril 2-3 times a day using a small cotton swab or gauze. Do not exceed the recommended dose. Method of administration Nasal use.

Contraindications

Hypersensitivity to the active substances, to other antiseptics such as: benzethonium chloride, cetyldimethylbenzylammonium chloride, cetylpyridinium chloride, methylbenzethonium chloride or to any of the excipients listed in section 6.1.

Side effects

Cases of hypersensitivity (burning or irritation) are possible, these effects are usually transient and do not require modification of the treatment. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

Special warnings

The medicine is for external use only. Avoid contact with eyes and middle ear. Do not use for prolonged treatments. After a short period of treatment without appreciable results, re-evaluate the therapy. Prolonged use, especially of medicines for local use, can give rise to sensitization phenomena; in this case, stop the treatment and institute a suitable therapy. Ingesting or inhaling some disinfectants can have serious, sometimes fatal, consequences. In case of accidental ingestion of the product, institute appropriate treatment (see section 4.9).

Pregnancy and breastfeeding

NEO-EMOCICATROL should be used only in case of real need.

Expiry and retention

Keep tightly closed away from heat.

Interactions with other drugs

Avoid simultaneous use of other antiseptics and detergents.

Overdose

Under normal conditions of use no overdose damage has been reported. Accidental ingestion can cause nausea and vomiting. Symptoms of intoxication resulting from the ingestion of significant quantities of quaternary ammonium compounds include dyspnoea, cyanosis, asphyxia resulting from paralysis of the respiratory muscles, CNS depression, hypotension and coma. Treatment of poisoning is symptomatic: administer soothing if necessary. Avoid emetics and gastric lavage.

Active principles

1 g of ointment contains: • active ingredients: benzalkonium chloride 1 mg and tannic acid 20 mg. For the full list of excipients, see section 6.1.

Excipients

Polyethylene glycol 400, polyethylene glycol 4000.